Family · Pharmaceutical analytical standards
Solifenacin
An antimuscarinic selective for the M3 receptors that control bladder muscle: developed in Japan, it was approved in 2004 for overactive bladder syndrome. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?The receptors it blocks are called muscarinic after muscarine, a substance isolated in 1869 from the fly agaric, Amanita muscaria, and used to tell them apart from other acetylcholine receptors.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
